Design of the EMPERIAL-preserved trial of empagliflozin in patients with chronic heart failure with preserved ejection fraction

被引:0
|
作者
Ponikowski, P. [1 ]
Abraham, W. T. [2 ]
Lindenfeld, J. [3 ]
Zeller, C. [4 ]
Macesic, H. [5 ]
Brueckmann, M. [6 ]
Salsali, A. [7 ]
Anker, S. D. [8 ]
机构
[1] Wroclaw Med Univ, Wroclaw, Poland
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[5] Boehringer Ingelheim Canada Ltd, Burlington, ON, Canada
[6] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[7] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[8] Charite, Berlin, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P269
引用
收藏
页码:48 / 49
页数:2
相关论文
共 50 条
  • [1] Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure
    Abraham, William T.
    Ponikowski, Piotr
    Brueckmann, Martina
    Zeller, Cordula
    Macesic, Hemani
    Peil, Barbara
    Brun, Michele
    Ustyugova, Anastasia
    Jamal, Waheed
    Salsali, Afshin
    Lindenfeld, Joann
    Anker, Stefan D.
    Abraham, William
    Anker, Stefan
    Lindenfeld, Joann
    Ponikowski, Piotr
    Brueckmann, Martina
    Salsali, Afshin
    Welty, Francine
    Clayton, Tim
    Greenberg, Barry
    Konstam, Marvin
    Lees, Kennedy
    Palmer, Mike
    Parhofer, Klaus
    Pedersen, Terje
    Carson, Peter
    Freston, James
    Kaplowitz, Neil
    Lewis, James
    Mann, Johannes
    Petrie, John
    Agostoni, Piergiuseppe
    Butler, Javed
    Desai, Akshay
    Filippatos, Gerasimos
    Howlett, Jonathan
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (07) : 932 - 942
  • [2] Design of the EMPERIAL trials of empagliflozin in patients with chronic heart failure with reduced or preserved ejection fraction
    Abraham, W. T.
    Anker, S. D.
    Salsali, A.
    Peil, B.
    Zeller, C.
    Brun, M.
    Macesic, H.
    Brueckmann, M.
    Lindenfeld, J.
    Ponikowski, P.
    DIABETOLOGIA, 2018, 61 : S323 - S324
  • [3] Design of the EMPERIAL-reduced trial of empagliflozin in patients with chronic heart failure with reduced ejection fraction
    Abraham, W. T.
    Ponikowski, P.
    Anker, S. D.
    Salsali, A.
    Peil, B.
    Brun, M.
    Brueckmann, M.
    Lindenfeld, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 411 - 412
  • [4] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21):
  • [5] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16): : 1451 - 1461
  • [6] Empagliflozin benefits in patients with heart failure and preserved ejection fraction
    Anker, Stefan D.
    Butler, Javed
    Usman, Muhammad Shariq
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans Pieter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Iwata, Tomoko
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    NATURE MEDICINE, 2022, 28 (12) : 2480 - 2481
  • [8] Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction EMPEROR-Preserved Trial
    Packer, Milton
    Butler, Javed
    Zannad, Faiez
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Carson, Peter
    Anand, Inder
    Doehner, Wolfram
    Haass, Markus
    Komajda, Michel
    Miller, Alan
    Pehrson, Steen
    Teerlink, John R.
    Schnaidt, Sven
    Zeller, Cordula
    Schnee, Janet M.
    Anker, Stefan D.
    CIRCULATION, 2021, 144 (16) : 1284 - 1294
  • [9] Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
    Ferreira, Joao Pedro
    Zannad, Faiez
    Vasques-Novoa, Francisco
    Neves, Joao Sergio
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Butler, Javed
    Packer, Milton
    Anker, Stefan D.
    EUROPEAN HEART JOURNAL, 2024,
  • [10] Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
    Boehm, Michael
    Butler, Javed
    Coats, Andrew
    Lauder, Lucas
    Mahfoud, Felix
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Brueckmann, Martina
    Hauske, Sibylle J.
    Schueler, Elke
    Wanner, Christoph
    Verma, Subodh
    Zannad, Faiez
    Packer, Milton
    Anker, Stefan D.
    EMPEROR Preserved Trial Committees Investigators
    EUROPEAN HEART JOURNAL, 2025, 46 (14) : 1304 - 1317